Back to search
FDAFDA · Food and drugs·Recall number D-0016-2026

Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar, Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-102-04.

Published October 22, 2025 · Recall initiated: October 6, 2025

Summary

FDA records drug Class II recall D-0016-2026, published October 22, 2025 and initiated October 6, 2025. Recalling firm: VIONA PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: 13080 bottles; Lot: Lot#: T400819, T400820, Exp 4/30/26; T401969, Exp 9/30/26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration

What to do

Voluntary: Firm initiated · Letter

Get an email if TAVABOROLE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TAVABOROLE
Manufacturer
VIONA PHARMACEUTICALS INC
Distributor
USA Nationwide
Lot
Lot#: T400819, T400820, Exp 4/30/26; T401969, Exp 9/30/26
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar, Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-102-04. recalled?

Yes. FDA published recall D-0016-2026 on October 22, 2025. Reported hazard: Discoloration

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TAVABOROLE.